LeadIQ logo
Learn more at LeadIQ.com

Insights

Expansion in Headcount Intra-Cellular Therapies recently increased its headcount by hiring 150 additional sales representatives, indicating a growth in their sales team that could present new sales opportunities.

Strategic Financing With recent financing of $575 million in a public offering, Intra-Cellular Therapies has secured additional capital, potentially leading to more resources for sales and business development activities.

Prominent Investors Noteworthy investors like M&G Plc and Lebenthal Lisanticg have made significant investments in Intra-Cellular Therapies, signifying confidence in the company's potential and opening avenues for strategic partnerships or collaborations.

Experienced Leadership The appointment of Sanjeev Narula as the Executive Vice President and Chief Financial Officer brings leadership with a strong background in finance, suggesting a focus on financial strategy that could create opportunities for sales growth and revenue generation.

Public Listing Intra-Cellular Therapies going public and raising substantial funding indicates a strengthened market presence and visibility, potentially attracting new investors, customers, and collaborators interested in their innovative treatments.

Similar companies to Intra-Cellular Therapies

Intra-Cellular Therapies Tech Stack

Intra-Cellular Therapies uses 8 technology products and services including Drupal, Google Font API, jQuery, and more. Explore Intra-Cellular Therapies's tech stack below.

  • Drupal
    Content Management System
  • Google Font API
    Font Scripts
  • jQuery
    Javascript Libraries
  • Webpack
    Miscellaneous
  • RSS
    Miscellaneous
  • PHP
    Programming Languages
  • MediaElement.js
    Video Players
  • Drupal Multisite
    Web Hosting

Media & News

Intra-Cellular Therapies's Email Address Formats

Intra-Cellular Therapies uses at least 1 format(s):
Intra-Cellular Therapies Email FormatsExamplePercentage
FLast@intracellulartherapies.comJDoe@intracellulartherapies.com
78%
First_Last@intracellulartherapies.comJohn_Doe@intracellulartherapies.com
17%
First@intracellulartherapies.comJohn@intracellulartherapies.com
3%
First.Last@intracellulartherapies.comJohn.Doe@intracellulartherapies.com
2%

Frequently Asked Questions

Where is Intra-Cellular Therapies's headquarters located?

Minus sign iconPlus sign icon
Intra-Cellular Therapies's main headquarters is located at 430 East 29th Street Suite 955 New York, New York 10016 US. The company has employees across 3 continents, including North AmericaAfricaEurope.

What is Intra-Cellular Therapies's phone number?

Minus sign iconPlus sign icon
You can contact Intra-Cellular Therapies's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Intra-Cellular Therapies's stock symbol?

Minus sign iconPlus sign icon
Intra-Cellular Therapies is a publicly traded company; the company's stock symbol is ITCI.

What is Intra-Cellular Therapies's official website and social media links?

Minus sign iconPlus sign icon
Intra-Cellular Therapies's official website is intracellulartherapies.com and has social profiles on LinkedIn.

How much revenue does Intra-Cellular Therapies generate?

Minus sign iconPlus sign icon
As of September 2024, Intra-Cellular Therapies's annual revenue reached $750M.

What is Intra-Cellular Therapies's SIC code NAICS code?

Minus sign iconPlus sign icon
Intra-Cellular Therapies's SIC code is 8732 - Commercial Economic, Sociological, and Educational Research NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Intra-Cellular Therapies have currently?

Minus sign iconPlus sign icon
As of September 2024, Intra-Cellular Therapies has approximately 702 employees across 3 continents, including North AmericaAfricaEurope. Key team members include Chief Financial Officer: S. N.Chief Medical Officer: S. D.Chief Financial Officer, Senior Vice President - Finance, Treasurer, Assistant Secretary: L. H.. Explore Intra-Cellular Therapies's employee directory with LeadIQ.

What industry does Intra-Cellular Therapies belong to?

Minus sign iconPlus sign icon
Intra-Cellular Therapies operates in the Pharmaceutical Manufacturing industry.

What technology does Intra-Cellular Therapies use?

Minus sign iconPlus sign icon
Intra-Cellular Therapies's tech stack includes DrupalGoogle Font APIjQueryWebpackRSSPHPMediaElement.jsDrupal Multisite.

What is Intra-Cellular Therapies's email format?

Minus sign iconPlus sign icon
Intra-Cellular Therapies's email format typically follows the pattern of . Find more Intra-Cellular Therapies email formats with LeadIQ.

How much funding has Intra-Cellular Therapies raised to date?

Minus sign iconPlus sign icon
As of September 2024, Intra-Cellular Therapies has raised $500M in funding. The last funding round occurred on Apr 17, 2024 for $500M.

When was Intra-Cellular Therapies founded?

Minus sign iconPlus sign icon
Intra-Cellular Therapies was founded in 2002.
Intra-Cellular Therapies

Intra-Cellular Therapies

Pharmaceutical ManufacturingNew York, United States501-1000 Employees

Intra-Cellular Therapies, Inc. is a biopharmaceutical company founded on Nobel prize-winning research that allows it to understand how therapies affect the inner-workings of cells in the body. The Company leverages this intracellular approach to deliver innovative treatments for people living with complex psychiatric and neurologic diseases.

WORK WITH US

Patient needs are at the core of our efforts at Intra-Cellular Therapies and we are always looking for talented individuals who share our values to join our team. Please explore open positions by clicking the “Jobs” tab above.

Section iconCompany Overview

Headquarters
430 East 29th Street Suite 955 New York, New York 10016 US
Phone number
SIC Code
8732 - Commercial Economic, Sociological, and Educational Research
Stock Symbol
ITCI
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2002
Employees
501-1000

Section iconFunding & Financials

  • $500M

    Intra-Cellular Therapies has raised a total of $500M of funding over 9 rounds. Their latest funding round was raised on Apr 17, 2024 in the amount of $500M.

  • $100M$1B

    Intra-Cellular Therapies's revenue is in the range of $100M$1B

Section iconFunding & Financials

  • $500M

    Intra-Cellular Therapies has raised a total of $500M of funding over 9 rounds. Their latest funding round was raised on Apr 17, 2024 in the amount of $500M.

  • $100M$1B

    Intra-Cellular Therapies's revenue is in the range of $100M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.